Shuttle pharmaceuticals holdings stock
WebAbout the Shuttle Pharmaceuticals Holdings Inc stock forecast. As of 2024 April 07, Friday current price of SHPH stock is 1.370$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Shuttle Pharmaceuticals Holdings stock price has been showing a declining tendency so we believe that similar market … WebShuttle Pharmaceuticals Holdings Inc stocks price quote with latest real-time prices, charts, financials, latest news, ... Shuttle Pharmaceuticals Holdings Inc. is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy.
Shuttle pharmaceuticals holdings stock
Did you know?
WebCompany profile page for Shuttle Pharmaceuticals Holdings Inc including stock price, company news, press releases, executives, board members, and contact information WebAccording to our current SHPH stock forecast, the value of Shuttle Pharmaceuticals Holdings, Inc. shares will drop by -5.39% and reach $ 1.348192 per share by March 22, 2024. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).SHPH stock recorded 9/30 (30%) green days with 8.63% …
WebSep 6, 2024 · ROCKVILLE, Md., Sept. 6, 2024-- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while reducing side effects, today announced the closing of its initial public offering (IPO) … WebMar 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company. It is focused on improving the outcomes of cancer …
WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. ... Stock prices can fluctuate wildly, and analyst ratings are provided to help self-directed traders evaluate securities. WebAug 31, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with ...
WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure …
polytec thermoplast idsteinWebCompany profile page for Shuttle Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information shannon farmsWebSHPH / Shuttle Pharmaceuticals Holdings Inc off-exchange short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in various trading venues. For more information on how to interpret this data, read this information notice provided by FINRA. Update Frequency: Daily at Close of Day shannon farms indianaWebApr 10, 2024 · A high-level overview of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. shannon farms woburn maWebShuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and ... shannon farms woburnWebApr 6, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) NASDAQ: SHPH · IEX Real-Time Price · USD. Add to Watchlist 1.39-0.06 (-4.14%) At close: Apr 6, 2024, 4:00 PM. 1.38 … shannon farms canal winchesterWebApr 5, 2024 · Shuttle Pharmaceuticals Holdings, Inc (NASDAQ: SHPH) is a discovery and development stage specialty pharmaceutical company focusing on cancer treatments and radiation therapy. Their Sept 2024 IPO was valued at … shannon farrell jacobs